Opinion
04-24-2015
In re REGLAN LITIGATION (Pliva, Inc.; Barr Pharmaceuticals, LLC; Barr Laboratories, Inc.; Watson Laboratories, Inc.; Actavis–Elizabeth, LLC; Teva Pharmaceuticals USA, Inc.; Mutual Pharmaceutical Company, Inc.; and United Research Laboratories, Inc.—Movants)
Opinion
It is ORDERED that the motion for leave to appeal is granted.